The estimated Net Worth of Oliver P Peoples is at least $867 Thousand dollars as of 1 October 2019. Oliver Peoples owns over 10,000 units of Yield10 Bioscience Inc stock worth over $74,391 and over the last 8 years he sold YTEN stock worth over $0. In addition, he makes $792,825 as President, Chief Executive Officer, and Director at Yield10 Bioscience Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Oliver Peoples YTEN stock SEC Form 4 insiders trading
Oliver has made over 4 trades of the Yield10 Bioscience Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of YTEN stock worth $5,600 on 1 October 2019.
The largest trade he's ever made was buying 10,000 units of Yield10 Bioscience Inc stock on 1 October 2019 worth over $5,600. On average, Oliver trades about 1,739 units every 4 days since 2017. As of 1 October 2019 he still owns at least 67,628 units of Yield10 Bioscience Inc stock.
You can see the complete history of Oliver Peoples stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Oliver Peoples biography
Dr. Oliver P. Peoples,(Olly) Ph.D. is a President, Chief Executive Officer, Director of the Company. He is co-founder of Metabolix, has served as our chief scientific officer since January 2000 and was previously our vice president of research and development. Dr. Peoples has served as a director since June 1992. Before founding Metabolix, Dr. Peoples was a research scientist with the Department of Biology at MIT. The research carried out by Dr. Peoples at MIT established the fundamental tools and methods for engineering bacteria and plants to produce polyhydroxyalkanoates. Dr. Peoples received a Ph.D. in Molecular Biology from the University of Aberdeen, Scotland. The Board believes that Dr. Peoples provides important technical and scientific understanding to the Board's analysis of Company strategy. As Chief Scientific Officer and a founder of the Company, Dr. Peoples has unique information related to the Company's research and technology and has led and directed many of our scientific research and development programs. Dr. Peoples also contributes to the Board's understanding of the intellectual property aspects of the Company's technology platforms.
What is the salary of Oliver Peoples?
As the President, Chief Executive Officer, and Director of Yield10 Bioscience Inc, the total compensation of Oliver Peoples at Yield10 Bioscience Inc is $792,825. There are 1 executives at Yield10 Bioscience Inc getting paid more, with Joseph Shaulson having the highest compensation of $1,394,220.
How old is Oliver Peoples?
Oliver Peoples is 58, he's been the President, Chief Executive Officer, and Director of Yield10 Bioscience Inc since 2016. There are 4 older and 3 younger executives at Yield10 Bioscience Inc. The oldest executive at Yield10 Bioscience Inc is Anthony Sinskey, 77, who is the Independent Director.
What's Oliver Peoples's mailing address?
Oliver's mailing address filed with the SEC is C/O YIELD10 BIOSCIENCE, INC., 19 PRESIDENTIAL WAY, SUITE 201, WOBURN, MA, 01801.
Insiders trading at Yield10 Bioscience Inc
Over the last 8 years, insiders at Yield10 Bioscience Inc have traded over $1,212,006 worth of Yield10 Bioscience Inc stock and bought 4,271,174 units worth $10,113,836 . The most active insiders traders include Jack W Schuler, Peter N Kellogg, and Joseph H Shaulson. On average, Yield10 Bioscience Inc executives and independent directors trade stock every 107 days with the average trade being worth of $238,638. The most recent stock trade was executed by Jack W Schuler on 20 December 2023, trading 36,000 units of YTEN stock currently worth $7,200.
What does Yield10 Bioscience Inc do?
yield10 bioscience, inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the united states and canada. the company, through its trait factory, is involved in developing high value seed traits for the agriculture and food industries. it also has an oilseed development center in saskatchewan, canada. yield10 bioscience, inc. has research agreements with bayer ag to develop traits in soybean; forage genetics international, llc to develop traits in forage sorghum; j. r. simplot company to develop novel traits in potato; and gdm seeds inc. to evaluate yield traits in soybeans. the company was formerly known as metabolix, inc. and changed its name to yield10 bioscience, inc. in january 2017. yield10 bioscience, inc. was founded in 1992 and is headquartered in woburn, massachusetts.
What does Yield10 Bioscience Inc's logo look like?
Complete history of Oliver Peoples stock trades at Yield10 Bioscience Inc
Yield10 Bioscience Inc executives and stock owners
Yield10 Bioscience Inc executives and other stock owners filed with the SEC include:
-
Joseph Shaulson,
Director -
Oliver Peoples,
President, Chief Executive Officer, Director -
Lynne Brum,
Vice President - Planning and Communications -
Charles Haaser,
Chief Accounting Officer, Vice President - Finance -
Anthony Sinskey,
Independent Director -
Richard Hamilton,
Director -
Sherri Brown,
Director -
Sarah Cecil,
General Counsel, Secretary -
Kristi Snell,
Chief Science Officer, Vice President - Research -
Robert Van Nostrand,
Chairman of the Board, Independent Director -
Peter N Kellogg,
Director -
Jack W Schuler,
-
Willie Loh,
Director